MPN patient cells display differential expression profiles of a subset of important mitotic regulators, including the SAC components BUB1, MAD2L1, INCENP, CDC20, CDK1, PLK1, and Aurora A/B. Here, CDK1 is linked to myeloproliferative neoplasm.